NASDAQ:INSM
Insmed Incorporated
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.insmed.comipo date
Jun 01, 2000
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptida...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus